Promising Results for Dialysis Patients with Chronic Pain

Chronic Pain in Kidney Patients

Chronic pain is prevalent among individuals undergoing dialysis, significantly impacting their daily activities and overall quality of life. Many common pain medications, such as NSAIDs and high-dose aspirin, are unsuitable for patients with kidney failure, limiting treatment options to acetaminophen and opioids, which may not always be the best choice.

Testing Pain Coping Skills

A recent study, conducted across 16 U.S. academic centers and 103 outpatient dialysis clinics, involved 643 participants receiving regular dialysis treatment. Led by Dr. Laura Dember from the University of Pennsylvania and funded by the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK), the research evaluated the effectiveness of a psychological intervention called Pain Coping Skills Training (PCST).

This program utilizes cognitive behavioral therapy techniques to equip patients with better strategies for managing pain and stress. Participants were randomly assigned to two groups: one received standard care, which included opioid-based pain medications when necessary, while the other group underwent PCST alongside their usual treatment. The PCST program included 12 weekly sessions facilitated by trained coaches, followed by 12 weeks of daily automated follow-up calls.

Benefits of Pain Coping Skills Training

The PCST sessions addressed various strategies aimed at alleviating pain-related anxiety, enhancing sleep quality, and fostering confidence in managing pain. After 12 weeks, participants in the PCST group exhibited significant improvements compared to those receiving standard care. Notably, the PCST group reported a marked reduction in pain interference with daily activities, as measured by a standardized pain questionnaire. Approximately 50% of the participants in the PCST group experienced noticeable pain relief, compared to only 36% in the standard care group.

Additionally, researchers noted improvements in secondary outcomes such as pain intensity, quality of life, depression, and anxiety. While these benefits were most pronounced during the initial 24 weeks, they slightly declined by the study’s conclusion at 36 weeks. Nonetheless, the psychological support provided by PCST appeared to have a lasting positive effect for many participants.

Addressing Pain Management Challenges

Dr. Dember emphasized the challenges of pain management for dialysis patients, stating, “There are limited medication options for these patients due to their kidney condition, making non-pharmacological solutions like PCST a vital area of research.” The study’s findings, published in JAMA Internal Medicine, highlight the significance of non-drug interventions for dialysis patients, as traditional pain medications, particularly opioids, pose risks of side effects and dependency. Thus, a safer approach like PCST could greatly enhance patient well-being.

Clinical Implications and Future Research

The study raises the possibility that talk therapy could alleviate chronic pain for dialysis patients. The diverse participant pool, which varied in age, ethnicity, and clinical backgrounds, enhances the credibility of the findings, making them applicable to a broad range of dialysis patients. High adherence to the program, with most participants completing the sessions, further indicates its relevance to real-world applications.

Although the improvements observed in the PCST group were described as modest, experts recognize that even small gains can significantly impact the lives of dialysis patients, who typically face multiple health challenges. As researchers advocate for further studies on the long-term benefits and cost-effectiveness of PCST, this trial offers hope for countless dialysis patients across the nation. With wider implementation, PCST has the potential to become an integral component of comprehensive care for individuals living with kidney failure.

References

1. Dember, L. M., Hsu, J. Y., Mehrotra, R., Cavanaugh, K. L., Kalim, S., Charytan, D. M., … & Cukor, D. (2024). Pain coping skills training for patients receiving hemodialysis: The HOPE Consortium randomized clinical trial. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2024.7140
2. National Institute of Diabetes and Digestive and Kidney Diseases. (2024). Helping to End Addiction Long-term Initiative (HEAL): Clinical trials for pain management. Retrieved from https://www.niddk.nih.gov
3. Keefe, F. J., Porter, L. S., Somers, T. J., Shelby, R. A., & Wren, A. V. (2020). Psychosocial interventions for managing pain in older adults: Evidence and recommendations. Pain Medicine, 21(1), 117–125. https://doi.org/10.1093/pm/pnz172
4. Morasco, B. J., & Krebs, E. E. (2019). Nonpharmacologic approaches to pain management in kidney disease. Clinical Journal of the American Society of Nephrology, 14(4), 618–626. https://doi.org/10.2215/CJN.12221018
5. Johansen, K. L., & Kurella-Tamura, M. (2018). Chronic pain in hemodialysis patients: Clinical challenges and treatment strategies. Seminars in Dialysis, 31(5), 493–498. https://doi.org/10.1111/sdi.12700
6. Charytan, D. M., & Unruh, M. (2019). The burden of chronic pain in patients with kidney failure: A call for improved care. Kidney International Reports, 4(10), 1301–1308. https://doi.org/10.1016/j.ekir.2019.08.014
7. Mehrotra, R., & Wetmore, J. B. (2020). The role of cognitive-behavioural therapy in the management of dialysis-related pain. Nephrology Dialysis Transplantation, 35(7), 1172–1178. https://doi.org/10.1093/ndt/gfz236
8. Steel, J. L., & White, P. L. (2022). Improving quality of life for dialysis patients through psychological support: Current evidence and future directions. Palliative Medicine Reports, 3(1), 45–52. https://doi.org/10.1089/pmr.2021.0043
9. Pain Medicines (Analgesics) | National Kidney Foundation. Accessed January 10, 2025. https://www.kidney.org/kidney-topics/pain-medicines-analgesics